LGD-4033 5mg
LGD-4033 is an investigational selective androgen receptor modulator for treatment of conditions such as muscle wasting and osteoporosis, currently under development by Ligand Pharmaceuticals.
| Trivial name | LGD-4033 5mg |
| Catalog Number | A14346-5 |
| Alternative Name(s) | 4-[(2R)-2-[(1R)-2,2,2-Trifluoro-1-hydroxyethyl]-1-pyrrolidinyl]-2-(trifluoromethyl)benzonitrile |
| Molecular Formula | C14H12F6N2O |
| CAS# | 1165910-22-4 |
| SMILES | C1C[C@@H](N(C1)C2=CC(=C(C=C2)C#N)C(F)(F)F)[C@H](C(F)(F)F)O |
| Size | 5mg |
| Supplier Page | http://www.adooq.com/lgd-4033.html |